Exhibit 99.1
AMERISOURCEBERGEN CORPORATION
SUMMARY SEGMENT INFORMATION
(in thousands)
(unaudited)
The following illustrates revised reportable segment revenue for the periods indicated:
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Fiscal Year Ended September 30, 2021 |
Revenue | | First Quarter | | Second Quarter | | Third Quarter | | Fourth Quarter | | Fiscal Year |
| | (As Revised) | | (As Revised) | | (As Revised) | | (As Revised) | | (As Revised) |
U.S. Healthcare Solutions | | $ | 51,572,581 | | | $ | 48,165,587 | | | $ | 50,375,842 | | | $ | 52,347,535 | | | $ | 202,461,545 | |
International Healthcare Solutions | | 944,311 | | | 989,032 | | | 3,030,769 | | | 6,565,517 | | | 11,529,629 | |
Intersegment eliminations | | (336) | | | (448) | | | (916) | | | (631) | | | (2,331) | |
Revenue | | $ | 52,516,556 | | | $ | 49,154,171 | | | $ | 53,405,695 | | | $ | 58,912,421 | | | $ | 213,988,843 | |
The following illustrates revised reportable segment operating income for the periods indicated:
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Fiscal Year Ended September 30, 2021 |
Segment Operating Income | | First Quarter | | Second Quarter | | Third Quarter | | Fourth Quarter | | Fiscal Year |
| | (As Revised) | | (As Revised) | | (As Revised) | | (As Revised) | | (As Revised) |
U.S. Healthcare Solutions | | $ | 565,927 | | | $ | 654,715 | | | $ | 529,790 | | | $ | 507,486 | | | $ | 2,257,918 | |
International Healthcare Solutions | | 50,989 | | | 51,843 | | | 100,831 | | | 186,623 | | | 390,286 | |
Total segment operating income | | $ | 616,916 | | | $ | 706,558 | | | $ | 630,621 | | | $ | 694,109 | | | $ | 2,648,204 | |
The following reconciles total segment operating income to income before income taxes for the periods indicated:
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Fiscal Year Ended September 30, 2021 |
(in thousands) | | First Quarter | | Second Quarter | | Third Quarter | | Fourth Quarter | | Fiscal Year |
Total segment operating income | | $ | 616,916 | | | $ | 706,558 | | | $ | 630,621 | | | $ | 694,109 | | | $ | 2,648,204 | |
Gains from antitrust litigation settlements | | — | | | — | | | 147,432 | | | 21,362 | | | 168,794 | |
LIFO credit | | 25,727 | | | 20,918 | | | 113,920 | | | 42,463 | | | 203,028 | |
Acquisition-related intangibles amortization | | (25,034) | | | (24,973) | | | (44,282) | | | (81,932) | | | (176,221) | |
Employee severance, litigation, and other | | (70,381) | | | (78,156) | | | (226,964) | | | (96,410) | | | (471,911) | |
Goodwill impairment | | — | | | — | | | — | | | (6,373) | | | (6,373) | |
Impairment of assets | | — | | | — | | | — | | | (11,324) | | | (11,324) | |
Operating income | | 547,228 | | | 624,347 | | | 620,727 | | | 561,895 | | | 2,354,197 | |
Other (income) loss | | (14,268) | | | 23,310 | | | (4,141) | | | (46,637) | | | (41,736) | |
Interest expense, net | | 33,614 | | | 34,526 | | | 51,338 | | | 54,596 | | | 174,074 | |
Income before income taxes | | $ | 527,882 | | | $ | 566,511 | | | $ | 573,530 | | | $ | 553,936 | | | $ | 2,221,859 | |